Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis
about
Routine deprescribing of chronic medications to combat polypharmacyQuantification of anticholinergic and sedative drug load with the Drug Burden Index: a review of outcomes and methodological quality of studiesDevelopment of a core outcome set for effectiveness trials aimed at optimising prescribing in older adults in care homes.Cost-effectiveness of mirabegron compared to tolterodine ER 4 mg for overactive bladder in Canada.Decreasing the load? Is a Multidisciplinary Multistep Medication Review in older people an effective intervention to reduce a patient's Drug Burden Index? Protocol of a randomised controlled trialAn Update on Geriatric Medication Safety and Challenges Specific to the Care of Older Adults.The effects of antimuscarinic treatment on the cognition of spinal cord injured individuals with neurogenic lower urinary tract dysfunction: a prospective controlled before-and-after study.Anticholinergic drug exposure is associated with delirium and postdischarge institutionalization in acutely ill hospitalized older patients.Risk of Mortality Associated with Anticholinergic Use in Elderly Nursing Home Residents with Depression.Anticholinergics: theoretical and clinical overview.Current and future pharmacotherapy for treating overactive bladder.Examination and Estimation of Anticholinergic Burden: Current Trends and Implications for Future Research.Audit of anticholinergic medication changes in older hospitalised patients using the Anticholinergic Drug Scale.A Novel Scale Linking Potency and Dosage to Estimate Anticholinergic Exposure in Older Adults: the Muscarinic Acetylcholinergic Receptor ANTagonist Exposure Scale.Heat Waves, Drugs with Anticholinergic Effects, and Outcomes in Older Hospitalized Adults.Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics.Medication Use and Fall-Related Hospital Admissions from Long-Term Care Facilities: A Hospital-Based Case-Control Study.Distressing Visual Hallucinations after Treatment with Trazodone.Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders.No Increased Risk of Fracture in Patients Receiving Antimuscarinics for Overactive Bladder Syndrome: A Retrospective Cohort Study.High prevalence of prescription of psychotropic drugs for older patients in a general hospital.Association Between Anticholinergic Drug Use and Health-Related Quality of Life in Community-Dwelling Older Adults.Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.Impact of hospitalization in an acute geriatric unit on polypharmacy and potentially inappropriate prescriptions: A retrospective study.The burden of central anticholinergic drugs increases pain and cognitive dysfunction. More knowledge about drug-interactions needed.Temporal changes in medication use and disease management in old age: where does it all end?The cholinergic system in the pathophysiology and treatment of Alzheimer's diseaseAnticholinergic burden and comorbidities in patients attending treatment with trospium chloride for overactive bladder in a real-life setting: results of a prospective non-interventional study
P2860
Q26775802-4691A45A-5C4B-4574-A549-E6A43D7727B1Q30240269-185C0F38-BE57-4154-B878-6141BA5A297EQ33555917-E34B5F93-581A-480D-8E5D-86746ACFD162Q33696642-6444A1D8-7CC3-407C-B5AB-8353062B0663Q36406116-B5C7ECA5-B94D-4F1E-B198-1666B078F9B6Q37025156-3164578A-14E9-4ED5-A3E2-39C3FD3B5737Q38635232-C2BCFB37-2925-4864-87F3-17153510DA1CQ38672176-6961829F-BA5E-4D16-8F59-A06DE6B8643AQ38705840-11CF83AA-B98E-4B5A-B86D-FBB132708552Q38769800-0FC89CC7-A74A-4623-AFC9-924A2BCF772DQ38851523-600E1BF0-C551-4A2F-8076-E4413C91BB13Q38886942-90EE2F17-DA87-4241-8AD9-EA9381F00AE7Q38946891-91534200-8863-419B-A7CD-1F66A33F77A3Q39019058-9C268ABB-4A3B-46C7-B51A-4B4673F692B8Q39290731-46119D65-1CE1-424C-8782-856A63D0B1C2Q40059162-8BCA5286-CDEB-4976-91D3-17B9FAF27CEEQ40176459-28892EA2-16D8-4054-9135-6FE280D27604Q40982884-4923DBD1-7DB7-4D70-B35E-E9F5499AB341Q41214474-1C078C48-A199-4BE4-B098-6C2DBB450BCDQ47189750-4E1135B6-0409-49EC-8EF6-824778784E18Q47569569-7416CA94-55DC-4766-85A4-CC98CF4D01F5Q47648971-D00ADE8F-3620-4A68-AAF3-FEBF526C306EQ47741746-09916CC6-EF33-40BE-8B56-DAC6BE6D98C2Q48259175-5D4EBDE8-7A81-4B38-B3DA-2CB082DA9D35Q50063290-3DB7960C-AF05-49F6-BB8F-DA4E33196E6FQ50139001-37F60B70-92A1-4756-9758-C4326615AE14Q57177786-1602BBC4-7C6E-4BF9-B2C7-97112BFD84A7Q58741609-3B7F6B3D-13F3-4050-9F6A-6147A00A4DF1
P2860
Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Drugs with anticholinergic eff ...... matic review and meta-analysis
@ast
Drugs with anticholinergic eff ...... matic review and meta-analysis
@en
Drugs with anticholinergic eff ...... matic review and meta-analysis
@nl
type
label
Drugs with anticholinergic eff ...... matic review and meta-analysis
@ast
Drugs with anticholinergic eff ...... matic review and meta-analysis
@en
Drugs with anticholinergic eff ...... matic review and meta-analysis
@nl
prefLabel
Drugs with anticholinergic eff ...... matic review and meta-analysis
@ast
Drugs with anticholinergic eff ...... matic review and meta-analysis
@en
Drugs with anticholinergic eff ...... matic review and meta-analysis
@nl
P2093
P2860
P31
P50
P356
P1476
Drugs with anticholinergic eff ...... matic review and meta-analysis
@en
P2093
Arduino A Mangoni
Kimberley Ruxton
Richard J Woodman
P2860
P304
P356
10.1111/BCP.12617
P407
P577
2015-05-20T00:00:00Z